Heart, Lung, Blood and Sleep Disorders
Last data update: May 02, 2024 . (Total: 47356 Documents since 2020)
Records 1-30 (of 60 Records) |
Query Trace: Pulmonary Embolism[original query] |
---|
Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants. Wada Noriaki, et al. Medicine 2023 0 0. (48) e36417 |
Real life treatment experience and outcome of consecutively hospitalised patients with SARS-CoV-2 pneumonia by Omicron-1 vs Delta variants. Giannitsioti Efthymia, et al. Infectious diseases (London, England) 2023 0 0. 1-10 |
Machine learning-based COVID-19 acute respiratory distress syndrome phenotyping and clinical outcomes: A systematic review. Tenda Eric Daniel, et al. Heliyon 2023 0 0. (6) e17276 |
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster. Marie-Joelle Jabagi et al. N Engl J Med 2023 3 (15) 1431-1432
At 21 days after the booster dose, we found no evidence of an increased risk of cardiovascular events among the recipients of the bivalent vaccine as compared with recipients of the monovalent vaccine. The evaluated events included ischemic stroke (hazard ratio, 0.86; 95% confidence interval [CI], 0.58 to 1.27), hemorrhagic stroke (hazard ratio, 0.86; 95% CI, 0.46 to 1.61), myocardial infarction (hazard ratio, 0.92; 95% CI, 0.62 to 1.36), pulmonary embolism (hazard ratio, 0.83; 95% CI, 0.49 to 1.40), and all four events combined (hazard ratio, 0.87; 95% CI, 0.69 to 1.09).
|
Evaluating the Performance of a Commercially Available Artificial Intelligence Algorithm for Automated Detection of Pulmonary Embolism on Contrast-Enhanced Computed Tomography and Computed Tomography Pulmonary Angiography in Patients With Coronavirus Disease 2019. Zaazoue Karim A, et al. Mayo Clinic proceedings. Innovations, quality & outcomes 2023 0 0. (3) 143-152 |
Association of preoperative COVID-19 and postoperative respiratory morbidity during the Omicron epidemic wave: the DROMIS-22 multicentre prospective observational cohort study. Garnier Marc, et al. EClinicalMedicine 2023 0 0. 101881 |
Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis. Kim Hye Jun, et al. Diabetes & metabolism journal 2023 0 0. |
Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program. Varma Jay K, et al. medRxiv : the preprint server for health sciences 2023 0 0. |
Purpura Fulminans After Varicella Infection and Pulmonary Embolism After COVID-19 Infection in Familial Mediterranean Fever: Coincidence or Not? Gezgin Yildirim Deniz, et al. Turkish archives of pediatrics 2023 0 0. (2) 234-236 |
Vaccination status and long COVID symptoms in patients discharged from hospital. Teresa Cristina D C Nascimento et al. Scientific reports 2023 2 (1) 2481
Ninety days after hospital discharge, patients with no or incomplete vaccination presented a higher frequency of symptoms (=?1) than patients with complete vaccination (40 vs. 27%; p?=?0.013). After adjusting for confounders, no or incomplete vaccination (odds ratio [OR] 1.819; 95% confidence interval [CI] 1.175–2.815), female sex (OR 2.435; 95% CI 1.575–3.764) and ICU admission during hospitalisation (OR 1.697; 95% CI 1.062–2.712) were independently associated with?=?1 symptom 90 days after hospital discharge. In conclusion, even in patients with severe COVID-19, vaccination mitigates the probability of long COVID symptoms.
|
A novel intelligent radiomic analysis of perfusion SPECT/CT images to optimize pulmonary embolism diagnosis in COVID-19 patients. Baeza Sonia, et al. EJNMMI physics 2022 0 0. (1) 84 |
Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism. Fiorentino Giuseppe, et al. Journal of thrombosis and thrombolysis 2022 0 0. |
Clinical characteristics analysis of COVID-19 patients from the first significant community outbreak by SARS-CoV-2 variant B.1.1.7 in Taiwan as experienced from a single northern medical center. Huang Ruei-Chang, et al. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2022 0 0. |
Early-stage COVID-19 pandemic observations on pulmonary embolism using nationwide multi-institutional data harvesting. Wismüller Axel, et al. NPJ digital medicine 2022 0 0. (1) 120 |
Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19. Xie JunQing, et al. JAMA internal medicine 2022 0 0. |
Early-stage COVID-19 pandemic observations on pulmonary embolism using nationwide multi-institutional data harvesting A Wismuller et al, NPJ Digital Medicine, August 19, 2022
We introduce a multi-institutional data harvesting (MIDH) method for longitudinal observation of medical imaging utilization and reporting. By tracking both large-scale utilization and clinical imaging results data, the MIDH approach is targeted at measuring surrogates for important disease-related observational quantities over time. To quantitatively investigate its clinical applicability, we performed a retrospective multi-institutional study encompassing 13 healthcare systems throughout the United States before and after the 2020 COVID-19 pandemic.
|
International electronic health record-derived post-acute sequelae profiles of COVID-19 patients HG Zhang et al, NPJ Digital Medicine, June 29, 2022
We leveraged electronic health record (EHR) data from 277 international hospitals representing 414,602 patients with COVID-19, 2.3 million control patients without COVID-19 in the inpatient and outpatient settings, and over 221 million diagnosis codes to systematically identify new-onset conditions enriched among patients with COVID-19 during the post-acute period. Compared to inpatient controls, inpatient COVID-19 cases were at significant risk for angina pectoris (RR 1.30, 95% CI 1.09–1.55), heart failure (RR 1.22, 95% CI 1.10–1.35), cognitive dysfunctions (RR 1.18, 95% CI 1.07–1.31), and fatigue (RR 1.18, 95% CI 1.07–1.30). Relative to outpatient controls, outpatient COVID-19 cases were at risk for pulmonary embolism (RR 2.10, 95% CI 1.58–2.76), venous embolism (RR 1.34, 95% CI 1.17–1.54), atrial fibrillation (RR 1.30, 95% CI 1.13–1.50), type 2 diabetes (RR 1.26, 95% CI 1.16–1.36) and vitamin D deficiency (RR 1.19, 95% CI 1.09–1.30).
|
COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles. Corriero Alberto, et al. Infectious disease reports 2022 0 0. (3) 492-500 |
Immunopathogenesis and immunogenetic variants in COVID-19. Sagulkoo Pakorn, et al. Current pharmaceutical design 2022 0 0. |
Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study. Lee Yi, et al. BMC infectious diseases 2022 0 0. (1) 462 |
COVID-19 vaccination in pregnancy. Kalafat Erkan, et al. American journal of obstetrics and gynecology 2022 0 0. |
Incidence of pulmonary embolism in COVID-19 infection in the ED: ancestral, Delta, Omicron variants and vaccines. Law Nicole, et al. Emergency radiology 2022 0 0. |
Pulmonary embolism in pediatric and adolescent patients with COVID-19 infection during the SARS-CoV-2 delta wave. Cohen Clay T, et al. Pediatric blood & cancer 2022 0 0. e29721 |
Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians. Lommatzsch Marek, et al. Respiration; international review of thoracic diseases 2022 0 0. (3) 307-320 |
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? Alkhatib Mohammad, et al. Microorganisms 2022 0 0. (2) |
Abdominal Computed Tomography Imaging Findings in Hospitalized COVID-19 Patients: A Year-Long Experience and Associations Revealed by Explainable Artificial Intelligence. Scarabelli Alice, et al. Journal of imaging 2021 0 0. (12) |
Anaplastic Lymphoma Kinase-Positive Primary Lung Adenocarcinoma Presenting With Pericardial Effusion and Tamponade in a COVID-19 Patient: A Case Report. Rahman Ateeb Ur, et al. Cureus 2021 0 0. (10) e19127 |
Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older MJ Jabagi et al, JAMA,November 22,2021
The BNT162b2 mRNA vaccine (Pfizer-BioNTech) was the first SARS-CoV-2 vaccine authorized and most widely used in older persons in France. Although no increases in cardiovascular events were reported in the phase 3 trials, questions emerged once the vaccine was used on a large scale because older people were underrepresented in the trials. In this nationwide study involving persons aged 75 years or older in France, no increase in the incidence of acute myocardial infarction, stroke, and pulmonary embolism was detected 14 days following each BNT162b2 mRNA vaccine dose.
|
Evidence Used to Update the List of Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19 CDC Science Brief, October 14, 2021
Chronic lung disease (including bronchiectasis, bronchopulmonary dysplasia, interstitial lung disease, pulmonary hypertension, pulmonary embolism, tuberculosis) and chronic liver disease (including cirrhosis, non-alcoholic fatty liver disease, alcoholic liver disease, and autoimmune hepatitis) were added September 2021 based on evidence published between December 1, 2019 and August 31, 2021 using the updated review methods outlined below. Mental health disorders (such as mood disorders including depression, and schizophrenia spectrum disorders) were added September 2021 based on evidence published between December 1, 2019 and August 31, 2021.
No conditions were removed from the previous underlying medical conditions list.
|
COVID-view: Diagnosis of COVID-19 using Chest CT. Jadhav Shreeraj, et al. IEEE transactions on visualization and computer graphics 2021 0 0. |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 02, 2024
- Content source: